Wikidata:Database reports/Constraint violations/P3098
Jump to navigation
Jump to search
Constraint violations report for ClinicalTrials.gov ID (Discussion, uses, items, changes, related properties): identifier in the ClinicalTrials.gov database
Data time stamp: (UTC) — Items processed: 391,561
The report is generated based on the settings on Property:P3098#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 391,561
The report is generated based on the settings on Property:P3098#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Single value" violations[edit]
Violations count: 1
- A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion (Q63571800): NCT00168324, NCT00168298
"Unique value" violations[edit]
Violations count: 15
- NCT00021333: Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated Radiation (Q59557280), Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer (Q66035585)
- NCT00293462: Management of Mucositis With GM-CSF (Sargramostim) Mouthwash Study Protocol (Q59494137), GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer (Q65538551)
- NCT00637637: Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study (Q59684881), External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases (Q64721308)
- NCT00844649: A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas (Q47477264), Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas (Q64681119)
- NCT02033499: Three Approaches to Glucose Monitoring in Non-insulin Treated Diabetes (Q64349125), Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-Insulin Treated Diabetes (Q93608553)
- NCT02297815: Comparative Effectiveness of Antibiotics for Respiratory Infections (Q64613639), Comparative Effectiveness of Broad- versus Narrow-Spectrum Antibiotics for Acute Respiratory Tract Infections in Children (Q93379220)
- NCT02578134: Q65316543, US-guided Percutaneous Electrolysis (EPE®) in Plantar Fasciosis (Q65317661)
- NCT02741674: PCORnet Bariatric Study (Q66406078), Comparing the Benefits and Harms of Three Types of Weight Loss Surgery -- The PCORnet® Bariatric Study (Q93611889)
- NCT02943304: Risk Evaluation of Fetal Nervous System and Neurodevelopment Disorders in Infants of Women Exposed to Zika Virus Infection During Pregnancy (Q27572265), Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero (Q60563348)
- NCT03282513: A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function (Q64818627), Q64835781
- NCT03891420: A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever (Q63580483), A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19 (Q107401595)
- NCT03894215: Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer (Q63579596), A Two-arm Randomized Non-comparative Phase 2 Trial of AGEN2034 (anti PD-1) as a Monotherapy or Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line) - RaPiDS (Q94794280)
- NCT03907891: Reducing Hopelessness Through Enhanced Physical Activity in Adults With Ischemic Heart Disease (Q63575799), Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations (Q107401638)
- NCT04010266: RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use (Q99529942), RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use (Q99529943)
- NCT04092270: A Study Combining the M3814 Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Patients (Q74281078), A Phase I/Ib Dose Escalation Study of Pegylated Liposomal Doxorubicin (PLD) With Peposertib (M3814) in Platinum - Resistant or Ineligible Ovarian and Related Cancers (Q124256988)
"Format" violations[edit]
Violations count: 2
- Antone R Opekun (Q91844126): nct01868373
- Q124058449: novalue
"Scope" violations[edit]
Violations count: 0
"Type clinical trial (Q30612)" violations[edit]
Violations count: 17
- polymenorrhea (Q3395659): menstrual cycle (Q83864)
- A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas (Q47477264):
- Management of Mucositis With GM-CSF (Sargramostim) Mouthwash Study Protocol (Q59494137):
- Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study (Q59684881):
- Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management (Q64601291):
- Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS (Q64611940):
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease (Q64661112):
- Cognitive and Memory Function in Patients With Fibromyalgia (Q64710040):
- Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma (Q64727454):
- Effects of Upper-limb Training Addition to a Conventional ET Program on PA Level and ADL Performance. (Q66044970):
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat (Q66394250):
- Antone R Opekun (Q91844126): human (Q5)
- Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-Insulin Treated Diabetes (Q93608553): research project (Q1298668), experiment (Q101965)
- A Two-arm Randomized Non-comparative Phase 2 Trial of AGEN2034 (anti PD-1) as a Monotherapy or Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line) - RaPiDS (Q94794280):
- Brain Plus Spinal Stimulation for Cervical SCI (Q113916777):
- Q124058449: part (Q15989253), sports discipline (Q2312410)
- Bolster Clinical Trial (Q125556939):
Types statistics[edit]
| Accepted | Type | Usage |
|---|---|---|
| Yes | clinical trial (Q30612) | 391510 |
| Yes | multicenter clinical trial (Q6934595) | 34 |
| Yes | clinical trials on Ayurveda (Q98446308) | 2 |
| No | experiment (Q101965) | 1 |
| No | research project (Q1298668) | 1 |
| No | part (Q15989253) | 1 |
| No | sports discipline (Q2312410) | 1 |
| Yes | phase IV clinical trial (Q42825046) | 1 |
| Yes | phase I clinical trial (Q5452194) | 1 |
| No | human (Q5) | 1 |
| No | menstrual cycle (Q83864) | 1 |
"Entity types" violations[edit]
Violations count: 0